EFFECTS OF RITUXIMAB PROPHYLAXIS ON THE AMOUNT OF FFP USED FOR ANTI-ABO ANTIBODIES IN BLOOD-TYPE-INCOMPATIBLE ADULT LIVING DONOR LIVER TRANSPLANTATION
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.